AVEX develops Footbeat, a first-in-class active recovery wearable that increases circulation by applying precise, cyclic pressure to the bottom/arch of the foot. Footbeat is described as clinically proven, non-invasive, mobile, and easy to use, addressing common complaints about existing devices such as immobility, noise, and discomfort. Co-founder Dr. David Mayer, a practicing orthopedic surgeon with more than 35 years of experience, led seven years of development and testing. The company positions Footbeat to improve health and athletic recovery and to drive better patient compliance and outcomes. AVEX announced plans to launch Footbeat in Q1 2017 and to make the device available to patients and physicians. The company raised capital to support production scale-up, operations hiring, and sales and marketing expansion.

Total raised

$8M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2017